BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 165 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $746 | -100.0% | 34,300 | -80.9% | 0.00% | -66.7% |
Q2 2022 | $2,475,000 | +294.7% | 179,200 | +549.3% | 0.00% | +200.0% |
Q1 2022 | $627,000 | -77.8% | 27,600 | -58.6% | 0.00% | -75.0% |
Q3 2021 | $2,819,000 | -5.0% | 66,600 | -19.2% | 0.00% | 0.0% |
Q1 2021 | $2,966,000 | +697.3% | 82,400 | +110.2% | 0.00% | – |
Q1 2020 | $372,000 | -24.1% | 39,200 | +29.6% | 0.00% | – |
Q4 2019 | $490,000 | +92.9% | 30,254 | +97.7% | 0.00% | – |
Q3 2019 | $254,000 | -87.6% | 15,300 | -87.3% | 0.00% | -100.0% |
Q2 2019 | $2,044,000 | -63.1% | 120,600 | -61.1% | 0.00% | -60.0% |
Q1 2019 | $5,544,000 | +3.9% | 309,900 | -30.1% | 0.01% | -16.7% |
Q4 2018 | $5,335,000 | -28.8% | 443,500 | +3.6% | 0.01% | -25.0% |
Q3 2018 | $7,488,000 | +199.0% | 427,900 | +82.3% | 0.01% | +700.0% |
Q2 2018 | $2,504,000 | +1651.0% | 234,700 | +744.2% | 0.00% | – |
Q1 2018 | $143,000 | -36.7% | 27,800 | -26.1% | 0.00% | – |
Q4 2017 | $226,000 | -54.4% | 37,599 | -56.7% | 0.00% | -100.0% |
Q3 2017 | $496,000 | – | 86,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
Penbrook Management LLC | 41,500 | $917,150 | 0.66% |